Skip to main content
. 2021 Oct 10;2:31. doi: 10.1186/s43556-021-00053-0

Fig. 3.

Fig. 3

Assessment of cell growth upon siCldn treatment. Cell growth of (a) LNCaP and (b) PC3 human prostate cancer cells following siCldn3 or siCldn4 treatment relative to growth following siSC. Data are shown as mean ± SD of 3 to 4 independent experiments. * represents p < 0.05 and *** represents p < 0.001